News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ALGS market cap is 59.47M. The company's latest EPS is USD -1.1587 and P/E is -0.69.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.11M | 3.54M | 2.72M | 6.89M | 3.24M |
| Operating Income | -18.95M | -22.68M | -23.92M | -19.14M | -18.21M |
| Net Income | -18.62M | -21.89M | -22.96M | -18.72M | -18.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 4.36M | 13.91M | 15.53M |
| Operating Income | -54.04M | -97.83M | -128.32M | -97.58M | -88.13M |
| Net Income | -52.26M | -108.54M | -128.33M | -96.05M | -87.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 164.07M | 146.69M | 121.74M | 106.13M | 85.85M |
| Total Liabilities | 42.06M | 42.79M | 36.99M | 36.5M | 31.03M |
| Total Equity | 122.01M | 103.9M | 84.75M | 69.64M | 54.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 146.52M | 265.3M | 235.37M | 146.69M | 151.53M |
| Total Liabilities | 29.33M | 45.26M | 50.64M | 42.79M | 59.45M |
| Total Equity | -64.89M | 220.04M | 184.73M | 103.9M | 92.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -62.61M | -79.39M | -22.39M | -36M | -56.34M |
| Investing | -37.9M | -26.29M | 19.99M | 45M | 44.99M |
| Financing | 43k | 164k | -1,000 | 413k | 392k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -46.77M | -74.26M | -115.66M | -79.39M | -79M |
| Investing | 6.79M | 32.76M | 3.02M | -26.29M | 44.98M |
| Financing | 85.53M | 192.35M | 78.68M | 164k | 88.33M |
| Market Cap | 59.47M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 3.9 |
| Price to Cash Ratio | 0.45 |
| Price to Book Ratio | 0.66 |
| Dividend Yield | - |
| Shares Outstanding | 75.67M |
| Average Volume (1 week) | 296.47k |
| Average Volume (1 Month) | 313.55k |
| 52 Week Change | -23.70% |
| 52 Week High | 1.38 |
| 52 Week Low | 0.5388 |
| Spread (Intraday) | 0.05 (5.66%) |
| Company Name | Aligos Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aligos.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
